[28PS3-am] Controlled release/Targeting

Tue. Mar 28, 2023 10:35 AM - 11:59 AM [Room PS3] (2F)

Chair: Kosuke Shimizu, Kosuke Kusamori

+Add all to schedule

10:35 AM - 10:47 AM

[28PS3-am07S] Hydroxyl PEG-modified liposomes caught by B cells are transported to other antigen presenting cells via complement receptors

○Yoshino Kawaguchi¹, Taro Shimizu¹, Hidenori Ando¹, Yu Ishima¹, Tatsuhiro Ishida¹ (1. Grad. Sch. Biomed. Sci., Tokushima Univ.)

10:47 AM - 10:59 AM

[28PS3-am08S] Evaluation of Tannic Acid for Sustained Release of Protein Drugs

○Kosei Utatsu¹, Risako Onodera¹, Keiichi Motoyama¹, Taishi Higashi^1,2 (1. Grad. Sch. Pharm. Sci., Kumamoto Univ., 2. Priority Organization for Innovation and Excellence)

10:59 AM - 11:11 AM

[28PS3-am09S] Development of a DDS technology using neutrophils for targeting inflammatory sites.

○Io Kageyama¹, Sei Yonezawa¹, Tomohiro Asai¹ (1. Department of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka)

11:11 AM - 11:23 AM

[28PS3-am10] Cell penetration assay of LNP (Lipid Nanoparticle) with
Cell Penetrating Peptides

○Motofumi Goto¹, Ryo Morofuji^1,2, Komei Okabe^1,2, Kazuhiro Kudo^1,2, Takahiro Honda^1,2 (1. NAIST, 2. Santen Pharmaceutical Co., Ltd.)

11:23 AM - 11:35 AM

[28PS3-am11S] A novel platform for antisense oligonucleotides to avoid off-target interactions

○CHISATO TERADA¹, ASAKO YAMAYOSHI¹, MARIKO HARADA-SHIBA², TSUYOSHI YAMAMOTO¹ (1. Grad. Sch. Biomed. Sci, Nagasaki Univ., 2. Osaka medical and pharmaceutical Univ.)

11:35 AM - 11:47 AM

[28PS3-am12S] Elucidation of intracellular kinetics of Am80-encapsulated lipid nanoparticles for efficient nuclear import of Am80 for curative COPD treatment

○Satoru Narukawa¹, Kazuaki Oda¹, Yuki Morita¹, Wakana Nemoto¹, Tomomi Akita¹, Yuta Nakai², Kota Tange², Chikamasa Yamashita¹ (1. Grad. Sch. Pharm. Sci., Tokyo Univ. Sci., 2. DDS Research Laboratory, NOF CORPORATION)

11:47 AM - 11:59 AM

[28PS3-am13] Percutaneous absorption control of poorly water-soluble substances by nanoemulsion technology with the world's smallest particle size of about 10 nm

○Satoshi Kamimura¹, Shingo Maruyama¹, Ami Fujihara¹, Yusuke Kinoshita¹, Taishi Yamashita¹ (1. MORESCO Corporation)

Session information

[28PS3-am] Controlled release/Targeting

[28PS3-am07S] Hydroxyl PEG-modified liposomes caught by B cells are transported to other antigen presenting cells via complement receptors

[28PS3-am08S] Evaluation of Tannic Acid for Sustained Release of Protein Drugs

[28PS3-am09S] Development of a DDS technology using neutrophils for targeting inflammatory sites.

[28PS3-am10] Cell penetration assay of LNP (Lipid Nanoparticle) with
Cell Penetrating Peptides

[28PS3-am11S] A novel platform for antisense oligonucleotides to avoid off-target interactions

[28PS3-am12S] Elucidation of intracellular kinetics of Am80-encapsulated lipid nanoparticles for efficient nuclear import of Am80 for curative COPD treatment

[28PS3-am13] Percutaneous absorption control of poorly water-soluble substances by nanoemulsion technology with the world's smallest particle size of about 10 nm

Authentication

Session information

[28PS3-am] Controlled release/Targeting

[28PS3-am07S] Hydroxyl PEG-modified liposomes caught by B cells are transported to other antigen presenting cells via complement receptors

[28PS3-am08S] Evaluation of Tannic Acid for Sustained Release of Protein Drugs

[28PS3-am09S] Development of a DDS technology using neutrophils for targeting inflammatory sites.

[28PS3-am10] Cell penetration assay of LNP (Lipid Nanoparticle) with Cell Penetrating Peptides

[28PS3-am11S] A novel platform for antisense oligonucleotides to avoid off-target interactions

[28PS3-am12S] Elucidation of intracellular kinetics of Am80-encapsulated lipid nanoparticles for efficient nuclear import of Am80 for curative COPD treatment

[28PS3-am13] Percutaneous absorption control of poorly water-soluble substances by nanoemulsion technology with the world's smallest particle size of about 10 nm

Authentication

[28PS3-am10] Cell penetration assay of LNP (Lipid Nanoparticle) with
Cell Penetrating Peptides